The main question is whether plasma concentrations of pro-inflammatory cytokines (IL-6, IL-1α, and TNF-α) can serve as predictive biomarkers for depression severity and whether these concentrations are modulated by gender among patients diagnosed with major depressive disorder (MDD). This evidence concerns the gene IL1A and depressive symptom measurement.